Pteroyl-L-monoglutamic acid
Brand names,
Pteroyl-L-monoglutamic acid
Analogs
Pteroyl-L-monoglutamic acid
Brand Names Mixture
Pteroyl-L-monoglutamic acid
Chemical_Formula
C19H19N7O6
Pteroyl-L-monoglutamic acid
RX_link
No information avaliable
Pteroyl-L-monoglutamic acid
fda sheet
Pteroyl-L-monoglutamic acid
msds (material safety sheet)
Pteroyl-L-monoglutamic acid
Synthesis Reference
No information avaliable
Pteroyl-L-monoglutamic acid
Molecular Weight
441.402 g/mol
Pteroyl-L-monoglutamic acid
Melting Point
250 oC
Pteroyl-L-monoglutamic acid
H2O Solubility
slight
Pteroyl-L-monoglutamic acid
State
Solid,orange to yellow crystalline powder
Pteroyl-L-monoglutamic acid
LogP
No information avaliable
Pteroyl-L-monoglutamic acid
Dosage Forms
No information avaliable
Pteroyl-L-monoglutamic acid
Indication
For treatment of folic acid deficiency, megaloblastic anemia and in anemias of nutritional supplements, pregnancy, infancy, or childhood.
Pteroyl-L-monoglutamic acid
Pharmacology
Folic acid, a water-soluble B-complex vitamin, is found in foods such as liver, kidneys, yeast, and leafy, green vegetables. Folic acid is used to diagnose folate deficiency and to treat topical sprue and megaloblastic and macrocytic anemias, hematologic complications resulting from a deficiency in folic acid.
Pteroyl-L-monoglutamic acid
Absorption
No information avaliable
Pteroyl-L-monoglutamic acid
side effects and Toxicity
IPR-MUS LD50 85 mg kg-1,IVN-GPG LD50 120 mg kg-1, IVN-MUS LD50 239 mg kg-1, IVN-RAT LD50 500 mg kg-1, IVN-RBT LD50 410 mg kg-1
Pteroyl-L-monoglutamic acid
Patient Information
No information avaliable
Pteroyl-L-monoglutamic acid
Organisms Affected
Humans and other mammals